Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial
Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M…
December 17, 2019 - 2 minutes
Promethera Biosciences
First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials
A stem cell therapy developed by the Belgian company Promethera has improved symptoms, such as…
April 15, 2019 - 2 minutes
How is Biotech Innovating to Treat Hemophilia? Let’s Review
Experts say hemophilia treatment is at a 'precipice of a therapeutic revolution.' From antibodies to…
February 13, 2018 - 7 minutes
Regenerating the Body With Stem Cells – Hype or Hope?
When the Japanese researcher Shinya Yamanaka managed to reprogram adult cells into an embryonic-like state…
July 11, 2017 - 9 minutes
Not to be Underestimated: What’s the Hype around NASH?
Since 2014, investment in Non-Alcoholic SteatoHepatitis (NASH) has taken off with a fervor reminiscent of…
February 7, 2017 - 10 minutes
“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”
Promethera is collecting cash to fuel its liver disease program that revolves around HepaStem. I…
November 21, 2016 - 7 minutes
Infographic: The Anatomy of European Biotech
Which part of our body do European biotechs prefer to target? And how diversified are…
December 10, 2015 - 1 minute
Louvain-la-Neuve: A Belgian temple for success in cell therapy
Artificial three-dimensional tissues to regenerate bones and soft tissues: Novadip Biosciences’ dream is a step…
September 15, 2015 - 2 minutes
Promethera Biosciences Raised €25,33M to Treat Liver Diseases
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment…
November 25, 2014 - 2 minutes
Belgian Promethera received approval to start World first Phase IIb/III stem-cell based urea cycle disorders treatment
Promethera is a promising Belgian Biotechnology company developing stem-cell based treatment against liver diseases. It…
October 25, 2014 - 1 minute
